These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 1642297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW, Peterson EA, Patel BC, Davis K.
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Survival factors in rhino-orbital-cerebral mucormycosis.
    Yohai RA, Bullock JD, Aziz AA, Markert RJ.
    Surv Ophthalmol; 1994 Jan; 39(1):3-22. PubMed ID: 7974189
    [Abstract] [Full Text] [Related]

  • 7. [Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis].
    Melero M, Kaimen Maciel I, Tiraboschi N, Botargues M, Radisic M.
    Medicina (B Aires); 1991 Jan; 51(1):53-5. PubMed ID: 1921693
    [Abstract] [Full Text] [Related]

  • 8. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O.
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
    Almannai M, Imran H, Estrada B, Siddiqui AH.
    Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832
    [Abstract] [Full Text] [Related]

  • 10. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z.
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mucormycosis--early diagnosis and treatment.
    Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L.
    Rev Laryngol Otol Rhinol (Bord); 2004 Mar; 125(2):127-31. PubMed ID: 15462174
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis.
    Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J.
    Rev Infect Dis; 1988 Mar; 10(3):551-9. PubMed ID: 3393782
    [Abstract] [Full Text] [Related]

  • 14. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M.
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [Abstract] [Full Text] [Related]

  • 15. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD, Ponssa XS, Rodríguez SD, Luna NC, Juárez CP.
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, Wang Q, Xu Q.
    BMC Ophthalmol; 2016 Jan 12; 16():10. PubMed ID: 26758904
    [Abstract] [Full Text] [Related]

  • 18. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R.
    Eur J Ophthalmol; 2022 Jul 12; 32(4):NP11-NP16. PubMed ID: 33843287
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.